Attached files
Exhibit
32.1
CERTIFICATION
PURSUANT TO
18
U.S.C. SECTION 1350
AS
ADOPTED PURSUANT TO
SECTION
906 OF THE SARBANES-OXLEY ACT OF 2002
In
connection with the Annual Report of Weikang Bio-Technology Group Co., Inc. (the
"Company") on Form 10-K for the year ended December 31, 2009 as filed with the
Securities and Exchange Commission on the date hereof (the "Report"), I, Yin
Wang, our Chief Executive Officer, certifies, pursuant to 18 U.S.C. 1350, as
adopted pursuant to §906 of the Sarbanes-Oxley Act of 2002, that, based on my
knowledge:
(1)
|
The
Report fully complies with the requirements of Section 13(a) or 15(d) of
the Securities Exchange Act of 1934; and
|
|
(2)
|
The
information contained in the Report fairly presents, in all material
respects, our financial condition and result of
operations.
|
WEIKANG
BIO-TECHNOLOGY GROUP CO., INC.
(Registrant)
|
||
Date:
March 31, 2010
|
By:
|
/s/ Yin Wang
Yin
Wan
|
Chief
Executive Officer
|